Clinical Bioprinting Is Coming of Age: <i>Ex Vivo</i> Versus <i>In Vivo</i> : Response to the Letter to the Editor

Vladimir A. Mironov, Alexey V. Kovalev

Open source

DOI
10.1177/19373368261450071
Published
2026-05-23
Container
Tissue Engineering Part B: Reviews
Publisher
SAGE Publications
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1177/19373368261450071,
  title = {Clinical Bioprinting Is Coming of Age:
                    <i>Ex Vivo</i>
                    Versus
                    <i>In Vivo</i>
                    : Response to the Letter to the Editor},
  author = {Vladimir A. Mironov and Alexey V. Kovalev},
  year = {2026},
  journal = {Tissue Engineering Part B: Reviews},
  doi = {10.1177/19373368261450071},
  url = {https://doi.org/10.1177/19373368261450071}
}

RIS

TY  - JOUR
TI  - Clinical Bioprinting Is Coming of Age:
                    <i>Ex Vivo</i>
                    Versus
                    <i>In Vivo</i>
                    : Response to the Letter to the Editor
AU  - Vladimir A. Mironov
AU  - Alexey V. Kovalev
PY  - 2026
JO  - Tissue Engineering Part B: Reviews
DO  - 10.1177/19373368261450071
UR  - https://doi.org/10.1177/19373368261450071
ER  - 

APA

Mironov, V. A., & Kovalev, A. V. (2026). Clinical Bioprinting Is Coming of Age: <i>Ex Vivo</i> Versus <i>In Vivo</i> : Response to the Letter to the Editor. Tissue Engineering Part B: Reviews. https://doi.org/10.1177/19373368261450071

Source records